Inhibition of vascular endothelial growth factor receptor tyrosine kinases impairs adipose tissue development in mouse models of obesity

Biochimica et Biophysica Acta - General Subjects

Volumn 1770, Issue 9, 2007, Pages 1369-1373

  Lijnen, H R ^a   Van Hoef, B ^a   Kemp, D ^b   Collen, D ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Adipose tissue; Obesity; Tyrosine kinase; Vascular endothelial growth factor (VEGF); VEGF receptor

Indexed keywords

MESSENGER RNA; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; VASCULOTROPIN RECEPTOR 2; VATALANIB;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL DIAMETER; BODY WEIGHT; C57BL 6 MOUSE; CONTROLLED STUDY; DENSITY; ENZYME INHIBITION; EXPERIMENTAL MODEL; GONAD; LIPID DIET; LIPOHYPERTROPHY; MALE; MOUSE; NONHUMAN; NUDE MOUSE; OBESITY; PRIORITY JOURNAL; RECEPTOR GENE; SUBCUTANEOUS FAT; WEIGHT REDUCTION;

ADIPOSE TISSUE; ANIMALS; DIETARY FATS; MALE; MICE; MICE, INBRED C57BL; MICE, NUDE; OBESITY; PHTHALAZINES; PYRIDINES; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR;

ANIMALIA; MURINAE; MUS; MUS MUSCULUS;

EID: 34547892290     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2007.06.001     Document Type: Article

References (23)

1. Varzaneh F.E., Shillabeer G., Wong K.L., and Lau D.C. Extracellular matrix components secreted by microvascular endothelial cells stimulate preadipocyte differentiation in vitro. Metabolism 43 (1994) 906-912
2. Rupnick M.A., Panigrahy D., Zhang C.Y., Dallabrida S.M., Lowell B.B., Langer R., and Folkman M.J. Adipose tissue mass can be regulated through the vasculature. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 10730-10735
3. Bråkenhielm E., Cao R., Gao B., Angelin B., Cannon B., Parini P., and Cao Y. Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice. Circ. Res. 94 (2004) 1579-1588
4. Voros G., Maquoi E., Demeulemeester D., Clerx N., Collen D., and Lijnen H.R. Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinology 146 (2005) 4545-4554
5. Silha J.V., Kirsek M., Sucharda P., and Murphy L.J. Angiogenic factors are elevated in overweight and obese individuals. Int. J. Obes. 29 (2005) 1308-1314
6. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declerq C., Pawling J., Moons L., Collen D., Risau W., and Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380 (1996) 435-439
7. Hausman G.J., and Richardson R.L. Adipose tissue angiogenesis. J. Anim. Sci. 82 (2004) 925-934
8. Tjwa M., Luttun A., Autiero M., and Carmeliet P. VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis. Cell. Tissue Res. 314 (2003) 5-14
9. Neufeld G., Cohen T., Gengrinovitch S., and Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13 (1999) 9-22
10. Fukumura D., Ushiyama A., Duda D.G., Xu L., Tam J., Krishna V., Chatterjee K., Garkavtsev I., and Jain R.K. Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis. Circ. Res. 93 (2003) 88-97
11. Wood J.M., Bold G., Buchdunger E., Cozens R., Ferrari S., Frei J., Hofmann F., Mestan J., Mett H., O'Reilly T., Persohn E., Rösel J., Schnell C., Stover D., Theuer A., Towbin H., Wenger F., Woods-Cook K., Menrad A., Siemeister G., Schirner M., Thierauch K.-H., Schneider M.R., Drevs J., Martiny-Baron G., Totzke F., and Marmé D. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Res. 60 (2000) 2178-2189
12. Mandrup S., Loftus T.M., MacDougald O.A., Kuhajda F.P., and Lane M.D. Obese gene expression at in vivo levels by fat pads derived from s.c. implanted 3T3-F442A preadipocytes. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 4300-4305
13. Neels J.G., Thinnes T., and Loskutoff D.J. Angiogenesis in an in vivo model of adipose tissue development. FASEB J. 18 (2004) 983-985
14. Lijnen H.R., Maquoi E., Holvoet P., Mertens A., Lupu F., Morange P., Alessi M.C., and Juhan-Vague I. Adipose tissue expression of gelatinases in mouse models of obesity. Thromb. Haemost. 85 (2001) 1111-1116
15. Giles A.R. Guidelines for the use of animals in biomedical research. Thromb. Haemost. 58 (1987) 1078-1084
16. Laitinen L. Griffonia Simplicifolia lectins bind specifically to endothelial cells and some epithelial cells in mouse tissues. Histochem. J. 19 (1987) 225-234
17. Lijnen H.R., Maquoi E., Morange P., Voros G., Van Hoef B., Kopp F., Collen D., Juhan-Vague I., and Alessi M.-C. Nutritionally induced obesity is attenuated in transgenic mice overexpressing plasminogen activator inhibitor-1. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 78-84
18. Blum W., Aichholz R., Ramstein P., Kühnöl J., Brüggen J., O'Reilly T., and Flörsheimer A. In vivo metabolism of epothilone B in tumor-bearing nude mice: identification of three new epothilone B metabolites by capillary high-pressure liquid chromatography/mass spectrometry/tandem mass spectrometry. Mass Spectrom. 15 (2001) 41-49
19. Arora A., and Scholar E.M. Role of tyrosine kinase inhibitors in cancer therapy. J. Pharmacol. Exp. Ther. 315 (2005) 971-979
20. Lin B., Podar K., Gupta D., Tai Y.-T., Li S., Weller E., Hideshima T., Lentzsch S., Davies F., and Li C. The vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584 inhibits growth and migration of multiple myeloma cells in the bone marrow microenvironment. Cancer Res. 62 (2002) 5019-5026
21. Rini B.I., and Small E.J. Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma. J. Clin. Oncol. 23 (2005) 1028-1043
22. Liu Y., Poon R.T., Li Q., Wai Kok T., Lau C., and Tat Fan S. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584. Cancer Res. 65 (2005) 3691-3699
23. Dussere E., Moulin P., and Vidal H. Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Biochim. Biophys. Acta 1500 (2000) 88-96